InsidersTradesSigma
HLB바이오스텝 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the HLB바이오스텝 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, HLB바이오스텝 has recorded 99 insider filings. Market capitalisation: €50.8bn. The latest transaction was disclosed on 1 July 2026 (Other). Among the most active insiders: 한국증권금융. Every trade is free.
99
Insider Decl.
0
Thresholds
€1m
13 ops.
Buy Volume
€39m
31 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,835 of 25,750 companies
33.0
score / 100
Value29
Quality37
FCF yld2.2%
Earn yld-40%
EV/EBITDA·
ROE-18%
Gross mgn76%
Net mgn-26%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations99 total
25 of 99 declarations
About HLB바이오스텝
HLB바이오스텝 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development of biopharmaceutical solutions.